When Should I Start Prostate Cancer Screening If High Risk?

Important Notice: This page is about screening for people who have not been diagnosed with prostate cancer and do not have symptoms. If you already have prostate cancer, your PSA testing schedule will be tailored to your treatment or active surveillance plan. If you are experiencing symptoms—such as blood in your urine or semen, or new urinary difficulties—you need a diagnostic evaluation, not a routine screening test.

If you have a family history of prostate cancer or are of Black ancestry, many medical guidelines (including those from the National Comprehensive Cancer Network, American Urological Association, and specific panels for Black men) recommend starting conversations about prostate-specific antigen (PSA) screening earlier than average-risk individuals—typically between ages 40 and 45 ^[1][2]. By getting a baseline PSA—your first PSA blood test that helps establish your personal reference level—in your early 40s, you and your doctor can decide how often you need to be screened in the future ^[1]. Note that screening recommendations must also be individualized for transgender women and nonbinary people with prostate tissue.

Understanding the Baseline PSA

Black men and men with a family history of the disease have a higher risk of developing prostate cancer and may develop it earlier than the general population ^[3][1]. A baseline PSA test between ages 40 and 45 provides an early look at your risk ^[1].

However, PSA is not a cancer diagnosis. A low PSA does not completely rule out cancer, and an elevated PSA can be caused by non-cancerous conditions like an enlarged prostate, inflammation, infection, or recent medical procedures ^[4]. Additionally, certain medications (like finasteride or dutasteride) can artificially lower your PSA level.

Some guidelines suggest your doctor may also offer a digital rectal exam (DRE)—where the doctor feels the prostate for physical abnormalities—alongside the PSA test for men at increased risk starting at age 40 ^[2]. A DRE does not replace the PSA test but can provide supplemental information.

Tailoring Your Screening Schedule

Your screening intervals are not set in stone; they depend on your age, baseline PSA, overall health, and specific risk factors. As an example of how a baseline PSA might guide your schedule:

• If your baseline PSA is low (e.g., under 1 ng/mL): Your doctor may suggest spacing out screenings to every 2 to 5 years, depending on the guideline ^[5][6].
• If your baseline PSA is higher (e.g., 1 to 3 ng/mL): You might need follow-up testing more frequently, such as every 1 to 2 years ^[5][6].
• If your baseline PSA is elevated (e.g., 3 ng/mL or higher): This is not a universal cutoff for an immediate biopsy. Usually, your doctor will first order a repeat PSA test to confirm the elevation and rule out temporary causes ^[5]. If it remains high, they may consider your prostate size, age, risk calculators, or an MRI (a detailed imaging scan) before discussing a biopsy ^[5][4].

The Role of Inherited Genetics and Family History

Your risk increases if you have multiple affected first-degree relatives (such as a father or brother), or if they were diagnosed at a young age ^[7][8].

For individuals with a strong family history, doctors often suggest genetic counseling to discuss testing for inherited mutations ^[9][10]. Mutations in genes like BRCA1, BRCA2, HOXB13, and ATM can significantly increase your risk of developing prostate cancer ^[11][12][13].

For men with certain known high-risk mutations, like BRCA2, specialists commonly discuss starting screening at age 40 ^[13][10]. In some high-risk families, a specialist may suggest starting screening up to 10 years before the youngest family member was diagnosed. However, this is a guideline-specific, specialist-guided option that usually has an age floor of 40, not a universal rule ^[10][13]. (Keep in mind that a negative genetic test does not eliminate all familial risk, and genetic results can also be important for your biological relatives’ health).

Weighing the Pros and Cons

Screening requires shared decision-making—a conversation where you and your doctor weigh the potential benefits and harms based on your personal values and overall health ^[14][15].

Potential Benefits:
While the direct evidence for mortality reduction specific to high-risk subgroups is still being studied, earlier screening may help catch aggressive cancers before they spread ^[16][17].

Potential Harms:

• False positives: An elevated PSA can cause anxiety and lead to unnecessary testing ^[18].
• Biopsy complications: Prostate biopsies can occasionally cause bleeding or infections ^[18].
• Overdiagnosis and Overtreatment: Screening can detect slow-growing cancers that would never have caused symptoms or shortened your life (overdiagnosis) ^[19]. Treating these cancers can cause permanent side effects, such as urinary incontinence (loss of bladder control) and erectile dysfunction ^[18][14]. Importantly, a diagnosis does not automatically mean treatment; active surveillance—careful, ongoing monitoring—is a common option for low-risk cancers. However, some high-grade cancers do progress and spread quickly, which is why appropriate screening and monitoring are critical.

When to Stop Screening

Guidelines, such as those from the U.S. Preventive Services Task Force (USPSTF), generally recommend considering screening only if you have a life expectancy of at least 10 to 15 years, as it takes years for the benefits of screening to outweigh the immediate harms of treatment ^[20][14].

While some guidelines suggest stopping routine screening around age 70 ^[14][1], this is not a strict rule. A healthy 70-year-old with a strong family history, Black ancestry, a known genetic mutation, and a long life expectancy may reasonably choose to continue screening after discussing the risks and benefits with their doctor.